Keyphrases
40 Years Old
25%
Anticoagulant Medications
50%
Anticoagulant Use
20%
Autopsy
25%
Basilar Artery
20%
Bulbar muscles
16%
Cerebral Vasospasm
50%
Cerebrospinal Fluid
50%
Conductive Textiles
16%
Cosmetic Surgery
40%
Cryptococcus Gattii
50%
Current Bias
16%
Current Sweep
16%
Direct Oral Anticoagulants
50%
Disease Progression
25%
E-textiles
50%
Early Recognition
25%
Early Treatment
25%
Fungal Infection
50%
Fungal Meningitis
20%
Fusarium Solani
50%
Gattii
25%
High Resistive State
16%
Immunocompetent Individual
25%
Intracranial Hemorrhage
50%
Ischemic Stroke
40%
Medical Tourism
50%
Memory Writing
16%
Memristor
50%
Meningitis
100%
Musculature
16%
Myasthenia Gravis
50%
New Treatment Options
16%
Non-endemic
25%
Non-volatile
50%
Non-volatile Switching
16%
Passive Devices
16%
Phase Change Material
16%
Reversal Agents
30%
Reversal Strategies
50%
Severe Infection
25%
Switching Response
16%
Texas
50%
Textile
50%
Vasospasm
30%
Vitamin K Antagonists
20%
Voltage Sweep
16%
Wales
16%
Write-once Memories
33%
Young Males
25%
Medicine and Dentistry
Angiography
10%
Anticoagulant
10%
Antifungal Therapy
10%
Antithrombotic
20%
Apoplexy
10%
Autoimmune Disease
12%
Awareness
25%
Basilar Artery
20%
Bleeding
20%
Brain Ischemia
40%
Brain Vasospasm
50%
Cerebral Hemorrhage
60%
Cerebrospinal Fluid
50%
Ciraparantag
10%
Cosmetics
30%
Cryptococcus gattii
50%
Dabigatran
10%
Direct Oral Anticoagulant
50%
Disease
50%
Disease Course
10%
Disease Exacerbation
25%
Drug Therapy
50%
Esthetic Surgery
20%
Exercise
12%
Fungal Meningitis
20%
Glucan
10%
Headache
20%
Health System
10%
Hydrocephalus
10%
Idarucizumab
10%
Infection
25%
Limb
12%
Meningitis
100%
Muscle Weakness
12%
Myasthenia gravis
50%
Mycosis
50%
Nicotinic Receptor
12%
Obstructive Hydrocephalus
10%
Papilledema
10%
Prevalence
12%
Prothrombinase
10%
Puncture
10%
Side Effect
20%
Spinal Anaesthesia
10%
Thrombin
10%
Vasospasm
30%
Vitamin K Antagonist
20%
Warfarin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
30%
Antivitamin K
20%
Autoimmune Disease
12%
Bleeding
20%
Blood Clotting Factor 10a
10%
Brain Hemorrhage
50%
Ciraparantag
10%
Cryptococcus gattii
50%
Dabigatran
10%
Direct Oral Anticoagulant
50%
Disease
50%
Disease Exacerbation
25%
Idarucizumab
10%
Infection
25%
Meningitis
50%
Muscle Weakness
12%
Myasthenia gravis
50%
Mycosis
50%
Nicotinic Receptor
12%
Prevalence
12%
Side Effect
20%
Thrombin
10%
Warfarin
10%
